From: Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Item | Cost (CAD) |
---|---|
Molecular test (Afirma) | 4938 |
Observation (for 1 year) | 466 |
Lobectomy | 4937 |
Complications associated with lobectomy | 4087 |
Follow up for benign pathology following lobectomy | 240 |
Follow up for malignant pathology following lobectomy | 466 |
Completion total thyroidectomy | 7269 |
Complications associated with completion thyroidectomy | 4094 |